Key insights
- The author expresses a bullish outlook on Veeva Systems (VEEV), citing its recent inclusion in the S&P 500, strong balance sheet, past earnings performance, attractive valuation, and competitive moat in the healthcare industry. The potential separation from Salesforce and the success of its Vault platform are also seen as positive catalysts. The author anticipates a positive earnings event on May 27th.
It popped up on my radar and the more I research it, the more bullish I am.
Just got added to SP500 so hopefully adds a floor,
0 debt and sitting on a cash mountain with a $2B buyback in place,
Decently outperformed in the last 5 quarters,
Pe sitting at about a third of its max,
Average analyst price target is 60% higher than what it is rn,
Ridiculous moat protection, it directly deals with healthcare and drug trials which have to be highly regulated and Veeva essentially have a monopoly on it which AI isn't going to disrupt any time soon.
Their "divorce" with salesforce if successful will rocket profit margins further and they are successful bringing a lot of clients onto their vault platform.
I truly believe it's crazily oversold and the earnings event on May 27th will hopefully show this. I'm bullish.